Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Escitalopram Stories

2009-02-25 22:26:02

U.S. authorities accused a New York pharmaceutical company Wednesday of making false claims about two antidepressants it markets for unapproved pediatric use. The civil complaint unsealed in U.S. District Court in Massachusetts, not only alleges Forest Laboratories Inc. marketed Celexa and Lexapro improperly but that it paid kickbacks to doctors to prescribe them. The U.S. attorney's office alleges the company's illegal promotional tactics caused thousands of false and fraudulent claims to be...

2009-02-25 15:04:00

Pharmaceutical Company Allegedly Marketed Drugs for Unapproved Pediatric Use and Paid Kickbacks WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- A Complaint was unsealed today in U.S. District Court in Massachusetts against a New York pharmaceutical company for alleged False Claims Act violations arising from the company's marketing the drugs Celexa and Lexapro for unapproved pediatric use and for paying kickbacks to induce physicians to prescribe the drugs. Acting Assistant Attorney General...

b15f66812eec8fbb658e618e6d9b96da1
2009-01-29 11:35:00

Researchers have concluded that Pfizer Inc's Zoloft and Forrest Laboratories Inc's Lexapro are superior antidepressant drugs compared to 12 other new drugs in their class. Doctors previously considered there to be very little difference between various antidepressants due to previous research, including one 2006 US government study that concluded that patients with major depression fared equally as well on various antidepressant drugs. However, after analyzing data from 117 studies...

1b7b257e245da92a4f328a31421e14521
2009-01-21 10:00:00

U.S. researchers announced on Tuesday that the antidepressant Lexapro seemed to ease anxiety in older adults, but the outcome is "modest" and requires further investigation. Antidepressants like Lexapro, which contains escitalopram, may be used for elder adults with a general kind of anxiety disorder, a situation that can create muscle tension, insomnia and exhaustion. Despite the benefits of escitalopram, the findings are slightly weakened from lack of adherence to the drug by some. "We...

2008-09-29 09:00:57

Q. Last night, my boyfriend became so violent, I was afraid he was going to hit my 22-year-old daughter or me. He threatened to burn down our home, and he tried to kick me out. I just realized that he started changing in the past two weeks right after he started taking Chantix to quit smoking. He has never acted like this before. He was so threatening and said such cruel and hateful things. I read on your Web site about possible violence and aggression from a combination of Chantix and...

2008-09-26 09:00:40

Adheris, Inc., a leader in patient adherence and education programs, announced today the results of a new study that examined adherence rates among patients on SSRI/SNRI antidepressant therapy. Study results showed that patients new to antidepressant treatment and those who had restarted therapy after a lapse of 6 or more months were twice as likely to discontinue therapy in the first 30 days of treatment versus patients previously dispensed an antidepressant. According to lead author...

2008-09-15 09:00:58

Lundbeck has announced that the FDA has completed the initial check for completeness and accepted the new drug application on Serdolect for the treatment of schizophrenia for review. Lundbeck said that this is the first new drug application (NDA) submitted in the US by the company, and it follows the launch of Serdolect in Europe, South and Central America, Asia and the Middle East. According to the company, Serdolect is an effective antipsychotic drug for the treatment of schizophrenia...

2008-08-20 09:01:30

Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced the appointment of Dr. Neil M. Sussman as Vice-President, Neurologic and Psychiatric Development of Biovail Technologies, Ltd. The appointment is effective immediately. Dr. Sussman brings a wealth of business and academic experience in the field of neurology and other central nervous system (CNS) disorders to Biovail. "We are delighted to have an individual as qualified as Dr. Sussman join our Medical and Scientific Affairs team,"...

2008-08-04 09:01:05

WARREN, N.J., Aug. 4 /PRNewswire/ -- MonoSol Rx, a specialty pharmaceutical company leveraging its proprietary drug delivery technology to develop thin film pharmaceutical products, today announced the completion of pilot product development for its thin film formulation of escitalopram oxalate, a selective serotonin reuptake inhibitor. Escitalopram oxalate is indicated for depression and generalized anxiety disorders and is marketed under the brand name Lexapro(R). Lexapro generated sales...

2008-07-15 09:01:35

WALTHAM, Mass., July 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that a drug's long-term efficacy in preventing recurrence of depressive mood episodes in patients who suffer from major depressive disorder, is the attribute that most influences psychiatrists' prescribing decisions in the treatment of this disorder. Clinical data and expert opinion show that current and emerging therapies...